MAM
SLS icon

Meeder Asset Management’s SELLAS Life Sciences SLS Stock Holding History

Meeder Asset Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-51
Closed -$3K – 1838
2018
Q4 		$3K Sell
51
-84
-62% -$6.5K ﹤0.01% 1525
2018
Q3 		$8K Buy
135
+108
+400% +$7.45K ﹤0.01% 1216
2018
Q2 		$4.63K Buy
27
+5
+23% +$1.37K ﹤0.01% 1294
2018
Q1 		$4K Buy
22
+11
+100% +$3.14K ﹤0.01% 1287
2017
Q4 		$4K Buy
11
+1
+10% +$484 ﹤0.01% 1382
2017
Q3 		$5K Buy
10
+9
+900% +$5.94K ﹤0.01% 1278
2017
Q2 		$1K Hold
1
– – ﹤0.01% 1550
2017
Q1 		$1K Hold
1
– – ﹤0.01% 1550
2016
Q4 		$3K Buy
+1
New +$5.82K ﹤0.01% 906

Other funds holding SLS

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return